Lung Cancer

Expand your education with ASCO eLearning courses, providing up-to-date clinical care learning courses for physicians, nurses and advanced practitioners.
This case-based course discusses implementation of recent clinical research findings regarding the use of adjuvant immunotherapy in stage I-III non—small–cell lung cancer.
This case-based course discusses implementation of recent clinical research findings regarding first-line treatment of advanced, non–small-cell lung cancer without driver mutations.
This course describes the epidemiology and risk factors for lung cancer. Practical approaches for promoting tobacco cessation, the leading lung cancer prevention strategy, are presented. Guideline recommendations for lung cancer screening are discussed. A patient case is included.
This case-based course reviews the role of surgery in lung cancer care, including types of resection and surgical approaches for staging and treatment. Evaluation of surgical candidacy and pre-operative assessments is also discussed.
This case-based course discusses the mechanisms of action and therapeutic indications for immune checkpoint inhibitors targeting PD-1/PD-L1 and CTLA4. Approaches for management of common immune checkpoint inhibitor toxicities are also outlined.
This course discusses common adverse effects associated with combined modality regimens containing immune checkpoint inhibitors. Unique challenges associated with combined modality therapy are described.

This site is intended for healthcare professionals in Europe and Japan only.

The selection of ASCO content on this site was made by the ASCO Publication and Education teams. Springer Healthcare selected the experts for interview. All content is made available solely for educational and informational purposes and personal use only.

© 2022 American Society of Clinical Oncology (ASCO®). All Rights Reserved.

This program is supported by an educational grant from Daiichi Sankyo and brought to you by Springer Healthcare | Contact Us | Privacy Policy

Before you go....

We'd love your feedback!

Your feedback will help guide us in the next phase of this program. Please take a few minutes (estimated 2 minutes) to answer the following 6 questions.